Researcher Carolyn Y. Fang, associate professor in the Cancer Preventionand Control Progam at Fox Chase Cancer Center, Philadelphia has released information in the February copy of Cancer Epidemiology, Biomarkers...
Natalie Morton recently died after receiving a shot for cervical cancer at her school in Coventry. Morton's death caused a scare regarding the HPV shot that all the girls in Natalie's school were receiving on Monday as part of a National Health Service immunization program. ...
created by Alyzee | 2 years ago 922 views | 0 recommendations | 3 comments
Since it's approval in the summer of 2006 by the Food and Drug Administration (FDA), 5 million girls and women, ages 9 to 26, have been vaccinated with GARDASIL.
GARDASIL, aggressively marketed by Merck &...
created by Karen Hatter | 2 years ago | updated 2 years ago 1212 views | 45 recommendations | 11 comments
This article states that the New England Journal of Medicine has posted articles questioning the distribution of GARDASIL, manufactured by Merck & Co. Inc and Cervarix, manufactured by...
created by Karen Hatter | 3 years ago | updated 3 years ago 911 views | 61 recommendations | 14 comments
Update: Effective July 1, 2008, in a press release dated July 24, 2008, the U.S. Citizenship and Immigration Services, adding human papillomavirus to the required list of vaccinations required when...
created by Karen Hatter | 3 years ago | updated 2 years ago 5962 views | 72 recommendations | 37 comments
The Center for Media and Democracy has completed a four part series of articles, The Politics and PR of Cervical Cancer, about the first FDA approved human papillomavirus (HPV) vaccine GARDASIL,...
created by Karen Hatter | 4 years ago | updated 4 years ago 4262 views | 25 recommendations | 7 comments
A quote from the American Cancer Society web site states:
Seventy percent (70%) of human papilloma virus (HPV) infections are typically gone within one year and 90% are gone within 2 years.
When I read this fact...
created by Karen Hatter | 4 years ago | updated 4 years ago 1611 views | 20 recommendations | 4 comments
In November 2006, Merck & Co. Inc. began its high pressure saturation 'One Less' campaign for its genetically engineered drug, GARDASIL, being hailed as a tool to prevent cervical cancer caused by two of...
created by Karen Hatter | 4 years ago | updated 4 years ago 3734 views | 25 recommendations | 8 comments